CinderBio Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.6M

  • Investors
  • 13

CinderBio General Information

Description

Developer of ultra-stable enzymes designed to increase efficiency in existing applications and expand the reach of enzymes into new markets and industries. The company's enzymes are made from microbes that thrive in hot volcanic waters around the globe and these are active and stable in both high heat and low pH and most detergents, enabling industries to do essential chemistry at a fraction of the cost of traditional methods with the added benefits of being faster, more efficient and biodegradable.

Contact Information

Website
www.cinderbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1933 Davis Street
  • Suite 208
  • San Leandro, CA 94577
  • United States
Primary Industry
Industrial Chemicals
Other Industries
Environmental Services (B2B)
Vertical(s)
CleanTech, Climate Tech, Life Sciences
Corporate Office
  • 1933 Davis Street
  • Suite 208
  • San Leandro, CA 94577
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CinderBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Grant 02-Apr-2020 $1.6M Completed Generating Revenue
13. Seed Round 12-Sep-2019 Completed Generating Revenue
12. Accelerator/Incubator 19-Sep-2018 Completed Generating Revenue
11. Grant 01-Jul-2018 Completed Generating Revenue
10. Accelerator/Incubator 09-May-2018 Completed Generating Revenue
9. Seed Round 22-Feb-2018 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
7. Grant 15-Apr-2016 Completed Generating Revenue
6. Accelerator/Incubator 15-Nov-2015 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
To view CinderBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CinderBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ultra-stable enzymes designed to increase efficiency in existing applications and expand the reach of enzym
Industrial Chemicals
San Leandro, CA
6 As of 2024

Darmstadt, Germany
 

Lyngby, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CinderBio Competitors (2)

One of CinderBio’s 2 competitors is Ab Enzymes (Pharmaceuticals), a Corporation company based in Darmstadt, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ab Enzymes (Pharmaceuticals) Corporation Darmstadt, Germany
Novonesis Corporation Lyngby, Denmark
You’re viewing 2 of 2 competitors. Get the full list »

CinderBio Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

CinderBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3701020-A1 Methods for rapidly digesting biopolymers with ultrastable enzymes for mass spectrometry-based analyses Pending 24-Oct-2017
CA-3080125-A1 Methods for rapidly digesting biopolymers with ultrastable enzymes for mass spectrometry-based analyses Pending 24-Oct-2017
US-20210063408-A1 Methods for rapidly digesting biopolymers with ultrastable enzymes for mass spectrometry-based analyses Pending 24-Oct-2017
AU-2018354264-A1 Methods for rapidly digesting biopolymers with ultrastable enzymes for mass spectrometry-based analyses Pending 24-Oct-2017
US-20190112562-A1 Enzymatic cleaning and sanitizing compositions and methods of using the same Inactive 06-Apr-2016 C11D3/48
To view CinderBio’s complete patent history, request access »

CinderBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CinderBio Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eunice Kennedy Shriver National Institute of Child Health and Human Development Government
Intertech Ventures Venture Capital Minority
Chobani Incubator Accelerator/Incubator
NIH Seed Not-For-Profit Venture Capital Minority
Activate Global Accelerator/Incubator
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

CinderBio FAQs

  • When was CinderBio founded?

    CinderBio was founded in 2012.

  • Where is CinderBio headquartered?

    CinderBio is headquartered in San Leandro, CA.

  • What is the size of CinderBio?

    CinderBio has 6 total employees.

  • What industry is CinderBio in?

    CinderBio’s primary industry is Industrial Chemicals.

  • Is CinderBio a private or public company?

    CinderBio is a Private company.

  • What is CinderBio’s current revenue?

    The current revenue for CinderBio is .

  • How much funding has CinderBio raised over time?

    CinderBio has raised $900K.

  • Who are CinderBio’s investors?

    Eunice Kennedy Shriver National Institute of Child Health and Human Development, Intertech Ventures, Chobani Incubator, NIH Seed, and Activate Global are 5 of 13 investors who have invested in CinderBio.

  • Who are CinderBio’s competitors?

    Ab Enzymes (Pharmaceuticals) and Novonesis are competitors of CinderBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »